John Demaree, Chief Commercial Officer

KPTI 7,500 shares

The estimated Net Worth of John Demaree is at least $109,012.50. John Demaree owns over 7,500 units of Karyopharm Therapeutics, Inc. stock worth over $109,012.50.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
26th August 2020KPTI - Karyopharm Therapeutics, Inc.7,500Open or private purchase7,500$14.54$109,012.50$109,012.50